Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Prognostic Model
Lauren E. Abrey(Lymphoma Study Association), Lisa M. DeAngelis(Memorial Sloan Kettering Cancer Center), Joachim Yahalom(Unknown), Walter J. Curran(Piedmont Cancer Institute), Minesh P. Mehta(Columbia University), Brian Berkey(RTOG Foundation), Steven A. Leibel(Mayo Clinic), Diana F. Nelson(Highland Hospital), Katherine S. Panageas(Mayo Clinic), Leah Ben‐Porat(Mayo Clinic), Christopher J. Schultz(Medical College of Wisconsin)
Cited by 620
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
How To Build and Interpret a Nomogram for Cancer Prognosis
|Journal of Clinical Oncology|2008|3.4k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k